Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFIRE: Antimalarials in Early Pregnancy
NCT06962319Phase 3Recruiting
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- Sep 2025
- Primary completion
- Aug 2028
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 3 trial of artesunate + pyronaridine, dihydroartemisinin + piperaquine in Plasmodium falciparum malaria, sponsored by Liverpool School of Tropical Medicine. Started Sep 2025; status: recruiting.
02
Drugs
artesunate + pyronaridinedihydroartemisinin + piperaquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT06962319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06962319.